A HISTORY OF GLOBAL SOLUTIONS
The Jean Boulle Group acquires promising assets and projects and optimizes their structure, management and development with private and public investment.
NEWS AND MEDIA
Trained Therapeutix Discovery Inc. Appoints Dr. Willem Mulder as Chief Scientific Officer - Expert in Use of Nanomaterials as Immunotherapeutics, Former Professor at Icahn School of Medicine at Mount Sinai, and Professor at Eindhoven University of Technology and Radboud University Medical Center
5 January, 2021
Trained Therapeutix Discovery, Inc. (“TTxD”), an immunotherapy biotech company founded by Jean Boulle Therapeutics, announces the appointment of Prof. Dr. Willem Mulder as Chief Scientific Officer effective 1 January 2021. [...]
24 December, 2020
The Jean Boulle Group is pleased to note the announcement today by Greenland Anorthosite Mining ApS (“GAM” or “the Company”) that the Greenlandic pension fund SISA Pension has invested in the Company. GAM is a mineral exploration and development company which has the potential to become a major supplier to the global fiberglass marketplace. [...]
Jean Boulle Medtech's company, VDYNE, Inc., receives major industry innovation award in recognition of ground-breaking transfemoral tricuspid valve replacement technology
December 14, 2020 - VDYNE, INC, Inc. ("VDYNE" or "the Company"), a privately held medical device company founded by Jean Boulle Medtech to develop a transcatheter replacement valve for the treatment of tricuspid regurgitation ("TR"), announced today that it is the co-recipient of the Innovations in Cardiovascular Interventions & High-Tech Science Industry World Startup Competition 2020. This award is one of the world's most significant and prestigious awards for medical interventions (ICI 2020). [...]
Copyright © 2019 Jean Boulle Group. All rights reserved.